Psychology

This World Autism Month, Autism Speaks Champions Change with New Community Messengers

Retrieved on: 
Tuesday, April 2, 2024

The program launch, part of Autism Speaks' celebration of World Autism Month and in recognition of its nearly two decades of impact, marks an evolution of collaborating with and standing alongside members of the autistic community.

Key Points: 
  • The program launch, part of Autism Speaks' celebration of World Autism Month and in recognition of its nearly two decades of impact, marks an evolution of collaborating with and standing alongside members of the autistic community.
  • Autism Speaks' Champions of Change will serve as messengers, advocates, allies and advisors for the nonprofit organization and to the autistic community at large — helping steer the future of the organization.
  • Alongside Autism Speaks, the Champions stand fearlessly for a world where autistic people are recognized, valued, celebrated and afforded the opportunities they deserve.
  • To show solidarity and support for Autism Speaks, New York City's Empire State Building will shine a spectrum of colors on Tuesday, April 2nd, to mark World Autism Awareness Day and celebrate the diversity of the autism community.

Lutris Pharma Appoints Life Sciences and Pharmaceutical Entrepreneur Moshe "Mori" Arkin to Its Board of Directors

Retrieved on: 
Monday, April 1, 2024

TEL AVIV, Israel, April 1, 2024 /PRNewswire/ -- Lutris Pharma , a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced the appointment Moshe "Mori" Arkin, a life sciences and pharmaceutical entrepreneur, and Founder and Chairman of Arkin Holdings, to its Board of Directors.

Key Points: 
  • TEL AVIV, Israel, April 1, 2024 /PRNewswire/ -- Lutris Pharma , a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced the appointment Moshe "Mori" Arkin, a life sciences and pharmaceutical entrepreneur, and Founder and Chairman of Arkin Holdings, to its Board of Directors.
  • "Mori is one of Israel's most successful life sciences and pharmaceutical entrepreneurs with an extraordinary background spanning decades in the industry," stated Antoni Ribas, M.D., Ph.D., Chairman and Founder of Lutris Pharma.
  • "Arkin Bio Ventures has been an investor in Lutris Pharma since its inception and has been a steadfast supporter of the Company, ever since.
  • In 2011, they formed the Arkin Family Foundation, which supports organizations and projects in education, arts and culture, welfare, healthcare, civil rights, and Jewish-Arab coexistence.

Lutris Pharma Appoints Life Sciences and Pharmaceutical Entrepreneur Moshe "Mori" Arkin to Its Board of Directors

Retrieved on: 
Monday, April 1, 2024

TEL AVIV, Israel, April 1, 2024 /PRNewswire/ -- Lutris Pharma , a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced the appointment Moshe "Mori" Arkin, a life sciences and pharmaceutical entrepreneur, and Founder and Chairman of Arkin Holdings, to its Board of Directors.

Key Points: 
  • TEL AVIV, Israel, April 1, 2024 /PRNewswire/ -- Lutris Pharma , a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced the appointment Moshe "Mori" Arkin, a life sciences and pharmaceutical entrepreneur, and Founder and Chairman of Arkin Holdings, to its Board of Directors.
  • "Mori is one of Israel's most successful life sciences and pharmaceutical entrepreneurs with an extraordinary background spanning decades in the industry," stated Antoni Ribas, M.D., Ph.D., Chairman and Founder of Lutris Pharma.
  • "Arkin Bio Ventures has been an investor in Lutris Pharma since its inception and has been a steadfast supporter of the Company, ever since.
  • In 2011, they formed the Arkin Family Foundation, which supports organizations and projects in education, arts and culture, welfare, healthcare, civil rights, and Jewish-Arab coexistence.

GA technologies Announces the Assumption of Office of Namika Sagara as its Executive Officer CBO

Retrieved on: 
Monday, April 1, 2024

TOKYO, March 31, 2024 /PRNewswire/ -- GA technologies Co., Ltd. (Head office: Minato district, Tokyo; President, Representative Director and CEO: Ryo Higuchi, Stock Code: 3491; Hereinafter as "the "Company") announces that Ms. Namika Sagara assumed office as the Executive Officer CBO (Chief Behavioral Officer) of the Company on April 1, 2024.

Key Points: 
  • TOKYO, March 31, 2024 /PRNewswire/ -- GA technologies Co., Ltd. (Head office: Minato district, Tokyo; President, Representative Director and CEO: Ryo Higuchi, Stock Code: 3491; Hereinafter as "the "Company") announces that Ms. Namika Sagara assumed office as the Executive Officer CBO (Chief Behavioral Officer) of the Company on April 1, 2024.
  • In 2013, she established Sagara Consulting LLC and became its representative.
  • Since then, she has been providing behavioral science consulting around the world, mainly incorporating behavioral economics.
  • After working as a postdoctoral fellow at the business school of Duke University, she founded Sagara Consulting LLC, a behavioral economics consulting company, and became its representative.

Student-Athletes with Self-Reported Autism Spectrum Disorder are More Likely to Score Low on Common Concussion Test, Raising the Need for Autism-Specific Comparison Data

Retrieved on: 
Thursday, March 28, 2024

PHILADELPHIA, March 28, 2024 /PRNewswire/ -- Schools and colleges across the country rely on Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) evaluations to assess and manage student-athlete concussions on the sidelines. However, this FDA-cleared tool is not recommended for student-athletes with neurodevelopmental disorders, who often score significantly lower than neurotypical individuals. New research published Feb. 13 in the Archives of Clinical Neuropsychology demonstrates the need for alternative or modified concussion assessment norms and the need for baseline testing for autistic athletes.

Key Points: 
  • However, this FDA-cleared tool is not recommended for student-athletes with neurodevelopmental disorders, who often score significantly lower than neurotypical individuals.
  • "The [neuropsychology] field needs to expand assessment and interpretation practices and procedures for people with ASD and related developmental conditions."
  • Individuals with attention deficit hyperactivity disorder (ADHD), learning disorder (LD) and ASD are not included in normative reference data.
  • This means when autistic athletes are assessed for a concussion, their data is compared to age- and gender-similar neurotypical individuals.

Cloverleaf Secures $7.3 Million Series A Extension Led by Advantage Capital

Retrieved on: 
Wednesday, March 27, 2024

CINCINNATI, March 27, 2024 /PRNewswire-PRWeb/ -- Cloverleaf, the leading automated coaching™ technology designed to bring out the best in workers and teams, announced today that it has secured a $7.3 million Series A extension funding round. The investment was led by Advantage Capital with participation from Conductive Ventures, Origin Ventures, ScOp Venture Capital, JobsOhio, Cintrifuse Capital and 1809 Capital.

Key Points: 
  • The investment was led by Advantage Capital with participation from Conductive Ventures, Origin Ventures, ScOp Venture Capital, JobsOhio, Cintrifuse Capital and 1809 Capital.
  • Cloverleaf is a truly innovative company changing the way businesses approach skills development for employees while also making a positive impact...
  • The company has tripled its revenue since its previous funding round in June 2022 and is expecting continued revenue growth with this new capital.
  • "Cloverleaf is a truly innovative company changing the way businesses approach skills development for employees while also making a positive impact," said Joe Henderson, Vice President, Advantage Capital.

Mindhappy Launches as the First of Its Kind, Mission-Driven Lifestyle Brand Promoting Mental Health and Well-Being Through the Power of Play and Creativity

Retrieved on: 
Tuesday, March 26, 2024

NEW YORK, March 26, 2024 /PRNewswire/ -- Mindhappy, the trailblazing lifestyle & wellness brand redefining well-being for the modern age, proudly launches direct-to-consumer today across the US. Grounded in psychology research, Mindhappy's first of its kind solutions are revolutionizing how individuals find relaxation and fulfillment in today's fast-paced world by embracing the joy of creativity and fostering meaningful connections.

Key Points: 
  • NEW YORK, March 26, 2024 /PRNewswire/ -- Mindhappy , the trailblazing lifestyle & wellness brand redefining well-being for the modern age, proudly launches direct-to-consumer today across the US.
  • Through innovative offerings rooted in play therapy, design thinking, and psychology research, the company creates imaginative activities with products that elicit calm and positivity.
  • "It's no secret that today's society is collectively struggling with mental health and well-being," says Darshita Raval, founder of Mindhappy.
  • In search of deeper meaning, she discovered the power of creative play through mindful, hands-on activities.

CACTUS forges partnership with American Psychological Association to Expand Access to High-Quality Psychology Research via R Discovery

Retrieved on: 
Tuesday, March 26, 2024

This collaboration aims to make high-quality psychology research accessible through R Discovery, the premier literature search and research reading app by CACTUS.

Key Points: 
  • This collaboration aims to make high-quality psychology research accessible through R Discovery, the premier literature search and research reading app by CACTUS.
  • Now all research content from APA's 90+ journals, covering a wide range of psychology and related disciplines, will be available on R Discovery.
  • This partnership between CACTUS and APA underscores a shared commitment to driving academic excellence by enhancing accessibility to research in psychology.
  • This partnership will enable universities and academic institutions to provide their communities access to R Discovery's comprehensive research database.

Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics

Retrieved on: 
Monday, March 25, 2024

The collection of interviews highlights the need for industry-wide transparency and integrity to meet the expected increase in global demand for aesthetics treatments.

Key Points: 
  • The collection of interviews highlights the need for industry-wide transparency and integrity to meet the expected increase in global demand for aesthetics treatments.
  • To drive words into action, Allergan Medical Institute (AMI) implemented an early injectors training program on ethics.
  • Allergan Aesthetics is also committed to continuing to develop patient-focused educational programs that look to address patients' needs and concerns.
  • With the launch of this initiative at AMWC 2024 in Monaco on the Allergan Aesthetics booth K2 (Ravel Floor) and more to follow in 2024, Allergan Aesthetics' Aesthetics-Ethics program is 'moving the needle on ethics' to shape an aesthetics industry fit for the future.

Pacific Oaks College & Children's School Announces Appointment of Three New Members to its Board of Trustees

Retrieved on: 
Thursday, March 21, 2024

PASADENA, Calif., March 21, 2024 /PRNewswire/ -- Pacific Oaks College , a nonprofit higher education institution committed to early childhood education and teacher preparation, recently announced the appointment of three new members to its Board of Trustees.

Key Points: 
  • PASADENA, Calif., March 21, 2024 /PRNewswire/ -- Pacific Oaks College , a nonprofit higher education institution committed to early childhood education and teacher preparation, recently announced the appointment of three new members to its Board of Trustees.
  • "We are delighted to welcome our three newest members to Pacific Oaks' Board of Trustees," said Leanne Wruck, Ph.D., Pacific Oaks interim president.
  • A second-generation trustee, Williams previously attended Pacific Oaks Children's School and is dedicated to continuing the institution's mission of excellence in education.
  • Pacific Oaks College, a Hispanic Serving Institution, is credited with pioneering anti-bias curricula and launching one of the nation's first Head Start training programs.